May 31-June 1, 2018
Dana-Farber Cancer Institute
As molecular testing becomes more widely adopted in the community oncology setting, cancer programs can benefit from access to innovative formats to help ensure that communication and quality patient care standards are maintained. Several innovative ACCC member programs have begun using virtual tumor board models as part of the integration of molecular testing into practice.
The virtual format allows participation by a variety of providers across a wide geographic area. Members of multidisciplinary teams across sites are invited to join in the virtual discussion of cases and determine treatment - regardless of the physical location of the patient and care team.
Building on interviews with select ACCC member programs, ACCC and our partner organization, the Association for Molecular Pathology (AMP), are developing a webinar series focused on virtual molecular tumor boards for lung and breast cancer. The 12-webinar series features case studies and robust discussions on molecular testing in the community setting.